Loading clinical trials...
Loading clinical trials...
TRUST Registry - Targeting Real World Usage In Stroke Treatment A WallabyPhenox Hemorrhagic Stroke Registry
TRUST Registry is an observational, prospective, long-term, post-market surveillance registry of subjects treated with WallabyPhenox flow modulation devices, stent systems, bifurcation aneurysm implants including their HPC variants (Hydrophilic Polymer Coating) where applicable as well as coil systems, and other adjunctive medical devices. The overarching purpose of this registry is to carry out a proactive gathering, recording, and analysis of data on the safety, performance and usability of the devices as applied within the routine practice of the participating registry sites.
Age
All ages
Sex
ALL
Healthy Volunteers
No
CHU Brest - Hôpital de La Cavale Blanche
Brest, France
Pitié Salpêtrière Hospital
Paris, France
Helios Klinikum Erfurt
Erfurt, Germany
Universitätsklinikum Hamburg-Eppendorf
Hamburg, Germany
University Hospital Heidelberg
Heidelberg, Germany
LMU Klinikum
München, Germany
Klinikum Nürnberg
Nuremberg, Germany
Cannizzaro Hospital in Catania
Catania, Italy
ASST Grande Ospedale Metropolitano Niguarda, Milano
Milan, Italy
Antonio Cardarelli Hospital- Naples
Naples, Italy
Start Date
January 29, 2026
Primary Completion Date
January 1, 2036
Completion Date
January 1, 2041
Last Updated
March 16, 2026
5,000
ESTIMATED participants
Aneurysm Treatment with a Neurovascular Flow Diverter
DEVICE
Dissection Treatment with a Neurovascular Flow Diverter
DEVICE
Perforation Treatment with a Neurovascular Flow Diverter
DEVICE
Arteriovenous Fistula treatment with a Neurovascular Flow Diverter
DEVICE
Aneurysm Treatment with Neurovascular Stent System
DEVICE
Atherosclerotic vascular stenosis Treatment with Neurovascular Stent System
DEVICE
Dissection Treatment with Neurovascular Stent System
DEVICE
Aneurysm treatment with Bifurcation Aneurysm Implant
DEVICE
Aneurysm treatment with Avenir Coil System
DEVICE
Arteriovenous fistula treatment with Avenir Coil System
DEVICE
Lead Sponsor
Phenox GmbH
NCT05436470
NCT05224219
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT03454490